Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Press release cover image

Aug 25, 2026

Press release

Flatiron Health Expands NSCLC Panoramic Dataset With Comprehensive Biomarker Data Model, Enabling Precision Medicine Research at Unprecedented Scale

AI-extracted biomarker data spanning 17+ markers across 345,000+ patients unlocks research across the full lung cancer continuumNEW YORK--(BUSINESS WIRE)--Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data, today announced the expansion of its non-small cell lung cancer (NSCLC) Panoramic dataset with a comprehensive biomarker data model, delivering specimen-level molecular detail at a scale of 345,000+ patients across ear
Press release cover image

Aug 25, 2026

Press release

Endeavor BioMedicines to Present Quantitative Image Analysis from Phase 2a Trial of Taladegib (ENV-101) at European Respiratory Society (ERS) Congress 2026

SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced that results from a High-Resolution Computed Tomography (HRCT) post hoc analysis from its Phase 2a trial evaluating taladegib (ENV-101) in individuals with idiopathic pulmonary fibrosis (IPF) have been accepted as a late-breaking abstract for presentation a
Press release cover image

Aug 25, 2026

Press release

Memorial Hermann Health System Deepens Partnership with Strategic Investment in PartsSource

Investment will help strengthen healthcare technology infrastructure and clinical capacity across more than 1,600 leading hospitals through the PartsSource platformCLEVELAND, Aug. 25, 2026 /PRNewswire/ -- PartsSource, the leading performance platform for clinical technology, today announced a strategic investment from Memorial Hermann Health System, a non-profit, award-winning health system committed to creating healthier communities, now and for generations to come.PartsSource provides device-o
Press release cover image

Aug 25, 2026

Press release

Beyond good intentions: What new industry research reveals about the patient-centricity gap in clinical trials, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn what new industry research, conducted by Everest Group, reveals about the gap between patient-centric goals and the realities of clinical trial delivery. The featured speakers will discuss where patient journeys still break down, how fragmented technology can increase site burden and what the data shows about the impact of patient-centric platforms. Attendees will also explore steps sponsors and CROs can take across technology, people and processes to improve patient-
Press release cover image

Aug 25, 2026

Press release

Lundbeck and EVERSANA Announce Strategic Partnership to Advance AI-Powered Commercialization

Collaboration expands deployment of EVERSANA's AI Agency platform and commercialization capabilities to advance Lundbeck's Focused Innovator strategy and bionic ambitions CHICAGO and DEERFIELD, Ill., Aug. 25, 2026 /PRNewswire/ -- Lundbeck, a global pharmaceutical company focused exclusively on brain health, and EVERSANA®, a leading global provider of commercial services to the life sciences industry, today announced a strategic partnership to advance AI-powered commercialization across Lundbeck'
Press release cover image

Aug 25, 2026

Press release

Brainomix to Present Five New Studies at ERS Congress Demonstrating the Potential of Quantitative CT in Interstitial Lung Disease (ILD)

OXFORD, England and CHICAGO, Aug. 25, 2026 /PRNewswire/ -- Brainomix, a global leader in AI-powered imaging for stroke and lung disease, today announced that five abstracts showcasing its proprietary biomarkers and advanced CT analysis technologies will be presented at the European Respiratory Society (ERS) Congress 2026, taking place September 5–9 in Barcelona, Spain.Continue Reading Brainomix 360 e-Lung is an FDA-cleared, CE-marked AI-powered image analysis tool that provides
A flat illustration of a human cell with a CRISPR tool, symbolizing gene editing.

Aug 25, 2026

New CRISPR Screening Service, Calla Lily Joins Wellcome Leap’s Program, Baylor College to Establish Xenoliver Transplant Center

Recent developments in the life sciences sector highlight significant advancements in technology and collaborations aimed at enhancing drug discovery and addressing critical health challenges.Bit.bio has introduced the ioScreen platform, a CRISPR screening service designed to facilitate human cell-based drug discovery. This platform allows researchers to manipulate gene activity, thereby deepening the understanding of disease mechanisms. Utilizing bit.bio's ioCells and other cell types, ioScreen
Press release cover image

Aug 24, 2026

Press release

Cohen Veterans Network Launches New Deployment Support Resource for Military Families

New online tool offers expert guidance and resources to help military families navigate each stage of the deployment cycleSTAMFORD, Conn., Aug. 24, 2026 /PRNewswire/ -- As military families across the country navigate the challenges of deployments and extended military assignments, Cohen Veterans Network (CVN), a global not-for-profit integrated network of mental health clinics for post-9/11 veterans, service members and their families, today launched a new Military Family Deployment Support Res
Press release cover image

Aug 24, 2026

Press release

Brightn Launches Complete Mental Health Benefit for Employer Groups: AI-Powered Daily Support + Licensed Therapy Nationwide Through OpenLoop Health

CEDAR RAPIDS, Iowa and DES MOINES, Iowa, Aug. 24, 2026 /PRNewswire/ -- OpenLoop, a national leader in telehealth-enabled clinical services, and Brightn, an AI-powered upstream mental wellness platform, today announced a strategic partnership to expand access to clinically-informed, preventive mental health support across healthcare, employer, and payer-aligned networks nationwide.Continue Reading The partnership connects Brightn's AI-driven, daily mental wellness experience with
Press release cover image

Aug 24, 2026

Press release

Ainnocence Reports 91.4% Program Success Rate Across 58 Antibody Affinity Maturation Campaigns, Opens 28-Program Biologics Pipeline to Licensing

Structure-free AI platform delivers picomolar leads while cutting wet-lab validation to 20-50 samples per roundAinnocence Inc., an AI-driven pharmaceutical & material IP-generatingplatform company, today reported performance results from 75 completed proteindesign programs and announced that it is seeking licensing and partneringagreements for 28 antibody, bispecific and ADC programs that have generatedpositive preclinical data across oncology, immunology and metabolicindications. Across 58a
Press release cover image

Aug 24, 2026

Press release

DeepCura Unveils the Electronic Health Workforce (EHW) -- the Step Beyond the EHR

Architected by founder Fern Cowan, the EHW is healthcare's system of evidenced action: a clinician-supervised AI workforce that does the practice's work on a finance-style ledger, where every action — and every entry in the chart — carries its receipt. It integrates with existing EHRs, or runs on its own.WILMINGTON, Del., Aug. 24, 2026 /PRNewswire/ -- DeepCura Inc., the bootstrapped healthcare-AI company whose platform is used by more than 6,000 clinicians across the United States, today unveile
Press release cover image

Aug 24, 2026

Press release

Zywave 2026 Midyear Market Outlooks: Agentic AI a Defining Force in Shaping Coverage, Benefits, and Workforce Strategy

MILWAUKEE, Wis., Aug. 24, 2026 /PRNewswire/ -- Zywave, the leading technology provider for insurance distribution, today released its four 2026 Midyear Market Outlook reports covering commercial insurance, employee benefits, human resources and wellness. While the four reports reveal the trends that defined the first half of 2026 in their respective markets, together, they deliver a resounding verdict: AI is no longer an exploratory talking point but is actively rewriting how risk and coverage g